

Request Sample Report
The Lyme Disease Diagnostics market is experiencing substantial growth, driven by increasing awareness and advancements in diagnostic technologies. The market size is projected to reach approximately $600 million by 2025, with a compound annual growth rate (CAGR) of about 8%. Enhanced testing methods and rising prevalence are key factors contributing to this expansion.
◍ Abbott Laboratories
◍ Abbott
◍ Bio-Rad
◍ Canon Life Sciences
◍ Global Lyme Diagnostics
◍ Graphene Frontiers
◍ Oxford Immunotec
◍ Trinity Biotech
The Lyme Disease Diagnostics Market features key players like Abbott Laboratories, Bio-Rad, and Trinity Biotech. These companies innovate with advanced testing methods, enhance accuracy, and broaden accessibility, driving market growth. While specific sales figures are proprietary, Abbott's overall diagnostics revenue is projected over $10 billion annually.
Request Sample Report
Hospitals ◍ Clinics ◍ Others
◍ Serological Tests
◍ Urine Antigen Tests
◍ Lymphocytic Transformation Tests
◍ Immunofluorescent Staining ◍ Nucleic Acid Tests
Request Sample Report
Request Sample Report
$ X Billion USD